ScreenerHero

SBTX SkinBioTherapeutics plc

LSE · GB · Healthcare · Biotechnology · skinbiotherapeutics.com
5.750GBp-4.17%Mkt Cap: 16.20M $P/E: —

SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, a…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap16.20M USD
Enterprise Value14.53M USD
Revenue (TTM)5.68M USD
Gross Profit3.11M USD
Net Income (TTM)-756.80K USD
Revenue/Share0.02 GBp
Last Price5.750 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees41
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)31.75
PEG—
EV/EBITDA-18.20
EV/Revenue2.56
P/S2.97
P/B1.94
EPS (TTM)0.00
EPS (Forward)0.00
52W Range
0.097525% of range23.00
52W High23.00 GBp
52W Low0.0975 GBp
Profitability
Gross Margin61.65%
Oper. Margin-46.53%
EBITDA Margin-14.05%
Profit Margin-15.01%
ROE-7.39%
ROA-5.74%
Growth
Revenue Growth37.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.34M USD
CapEx (TTM)172.64K USD
FCF Margin-26.90%
FCF Yield-9.44%
Net Debt-2.38M USD
Net Debt/EBITDA2.98
Balance Sheet
Debt/Equity0.11
Current Ratio6.14
Quick Ratio4.96
Book Value/Sh0.03 GBp
Cash/Share0.01 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 GBp
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)29.00 GBp
Upside (mean)+404.3%
Target Range29.00 GBp – 29.00 GBp
# Analysts1
Ownership
Shares Out.259.17M
Float116.00M
Insiders41.14%
Institutions13.41%
Technical
SMA 509.285 (-38.1%)
SMA 2009.579 (-40.0%)
Beta0.10
S&P 52W Chg14.58%
Avg Vol (30d)4.06M
Avg Vol (10d)11.85M
Technical Indicators
RSI (14)16.4
MACD-1.0576
MACD Signal-0.9739
MACD Hist.-0.0838
BB Upper10.62 GBp
BB Middle7.475 GBp
BB Lower4.330 GBp
BB Width84.15%
ATR (14)0.7987 GBp
Vol Ratio (20d)0.01x